Feedback PLC (LON:FDBK)

Feedback PLC (LON:FDBK)

Share Price
0.95 p
0.0049 (0.52 %)
Market Cap
£3.56 m
Proactive Investors - Run By Investors For Investors

Feedback PLC RNS Release

Feedback retains industry standard certification

RNS Number : 2381I
Feedback PLC
22 November 2018

Feedback plc


Feedback Medical Ltd retains international medical devices industry standard certification following independent audit


Cambridge, 22 November 2018: Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the specialist medical imaging technology company, announces that its operating company, Feedback Medical Ltd, has retained its ISO 13485:2016 certification for the fourth consecutive year.

ISO 13485:2016 is the internationally recognised 'Medical Devices Quality Management' standard specifying that organisations demonstrate their ability to provide medical devices and related services that consistently meet customer and regulatory requirements. 

Feedback Medical Ltd's continued compliance with this standard illustrates the importance that it places on the quality of its products and customer support. The certification was awarded following a surveillance audit by independent compliance specialists SGS UK Ltd. 

Dr Stephen Brown, Feedback Medical Ltd's Quality and Regulatory Compliance Director, said:

"This successful audit demonstrates our dedication to ensuring that our products are safe, effective and reliable. We strive to meet and exceed our customer's expectations and international quality standards, in the face of ongoing change within the regulatory landscape of our target markets."


- ENDS -


For further information, please contact:


Feedback plc

Alastair Riddell, Executive Chairman

Lindsay Melvin, CFO


+44 (0)1954 718072

[email protected]

Instinctif Partners

Rozi Morris/ Deborah Bell/ Phillip Marriage

+44 (0)20 7457 2020

[email protected]


Notes to editors


About Feedback plc

Feedback plc (AIM: FDBK) is a specialist medical imaging technology company providing innovative software and systems, through its fully-owned trading subsidiary, Feedback Medical Limited. Its products advance the work of radiologists, clinicians and medical researchers by improving workflows and giving unique insights into diseases, particularly cancer. Feedback Medical works with customers globally from headquarters in the internationally renowned scientific hub of Cambridge, UK. Its proprietary technologies are TexRAD®, the quantitative texture analysis tool and Cadran, a picture archiving communication system (PACS). For more information, see

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

Feedback PLC Timeline

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use